학술논문
Ocrelizumab versus fingolimod after natalizumab cessation in multiple sclerosis: an observational study
Document Type
Article
Author
Source
In: Journal of Neurology . (Journal of Neurology, June 2022, 269(6):3295-3300)
Subject
Language
English
ISSN
14321459
03405354
03405354